Xenon Pharmaceuticals (XENE) Prepaid Assets (2013 - 2026)

Xenon Pharmaceuticals (XENE) has 14 years of Prepaid Assets data on file, last reported at $10.7 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 47.68% year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a 47.68% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 50.83% from the prior year.
• Prepaid Assets for Q1 2026 stood at $10.7 million, up from $10.4 million in the prior quarter.
• Over the last five years, Prepaid Assets for XENE reached as high as $17.1 million in Q3 2025 and fell as low as $2.9 million in Q2 2023.
• Historically, Prepaid Assets has averaged $7.2 million across 5 years, with a median of $6.8 million in 2024.
• Across the five-year window, Prepaid Assets tumbled 58.53% in 2023 and jumped 264.0% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $7.2 million in 2022, then retreated by 16.87% to $6.0 million in 2023, then advanced by 14.72% to $6.9 million in 2024, then soared by 50.83% to $10.4 million in 2025, then advanced by 3.16% to $10.7 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $10.7 million in Q1 2026, $10.4 million in Q4 2025, and $17.1 million in Q3 2025.